Results 141 to 150 of about 5,873,812 (294)

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

MEASUREMENT OF THE INHERENT GROWTH ENERGY OF TISSUES [PDF]

, 1923
Alexis Carrel
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Bioinformatic Analysis and Molecular Docking Identify Isorhamnetin Is a Candidate Compound in the Treatment of Pulmonary Artery Hypertension. [PDF]

Anatol J Cardiol
Shao C, Xia W, Liu Y.
europepmc   +1 more source

Studies on the Growth of TissuesIn Vitro [PDF]

, 1937
F. Jacoby, O. A. Trowell, E. N. Willmer
openalex   +1 more source

Growth and Growth Charts in Children [PDF]

JAMA Pediatrics, 2018
Lindsay A. Thompson, Megan A. Moreno
openaire   +3 more sources

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Cognitive loopholes of crime: Mapping the Codevelopment of moral disengagement within perceptions of risks and rewards. [PDF]

J Res Adolesc
Decrop R, McManamon B, Williams K, Houlihan K, Bok HC, Knestrick K, Rodgers E, Docherty M, Cauffman E.   +8 more
europepmc   +1 more source

On the cytology of malignant growths

, 1906
J. BRETLAND FARMER, J. E. S. Moore, Claire Walker   +2 more
openalex   +1 more source

ON THE PREPARATION OF SALT-FREE CULTURE MEDIA AND THE GROWTH OF BACTERIA UPON THEM [PDF]

, 1905
Alonzo Englebert Taylor
openalex   +1 more source